Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Kumovis, a Germany-based 3D printing equipment spinout of Technical University of Munich focused on medical clients, has secured €3.6m ($4m) of series A capital from investors including public-private partnership High-Tech Gründerfonds. The round also included thermoplastic film producer Renolit and Solvay Ventures, the corporate venturing fund for chemicals firm Solvay, as well as Ffilipa Venture Capital. Founded in 2017, Kumovi has built a 3D printer specifically tailored to making a variety of thermoplastics in decentralised clean rooms where medical products are developed. The aim is to create a swifter supply chain for thermoplastic medical parts. The series A cash will enable Kumovi to refine its 3D printing technology while targeting additional, unspecified markets.
Re-Vana Therapeutics, a UK-based chronic eye disease treatment producer spun out of Queen’s University of Belfast (QUB), has secured $3.3m of seed capital from ophthalmic-focused venture funds ExSight, Visionary Ventures and InFocus, the Irish Times reported…
